Literature DB >> 15134324

Disseminated cutaneous acanthamebiasis: a case report and review of the literature.

Michael Paltiel1, Eric Powell, Jane Lynch, Bryan Baranowski, Ciro Martins.   

Abstract

The genus Acanthamoeba includes species of free-living soil and water ameba that have been implicated in a small number of human diseases. Acanthamoeba species have been identified as the etiologic agents in 2 well-defined clinical entities, amebic keratitis and granulomatous amebic encephalitis (GAE). Less commonly, Acanthamoeba species have been identified as the cause of disseminated disease in debilitated and immunocompromised patients. Cutaneous acanthamebiasis, often a reflection of disseminated disease, is an increasingly recognized infection since the emergence of acquired immunodeficiency syndrome (AIDS) and the use of immunosuppressive drugs. The disease portends a poor prognosis and is uniformly fatal if the infection involves the central nervous system (CNS). We describe a patient with advanced AIDS who presented with disseminated cutaneous lesions, headache, and photophobia, and in whom a diagnosis of cutaneous acanthamebiasis was made based on the results of a skin biopsy. A multidrug therapeutic regimen was begun that included sulfadiazine; the patient responded favorably to treatment. This paper also reviews 36 previously reported cases of cutaneous acanthamebiasis with delineation of clinical, diagnostic, histologic, and prognostic features, as well as discusses treatment options.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134324

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  8 in total

Review 1.  The Development of Drugs against Acanthamoeba Infections.

Authors:  Ruqaiyyah Siddiqui; Yousuf Aqeel; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

2.  Acanthamoeba endophthalmitis during treatment for cutaneous disease in a renal transplant patient.

Authors:  Allison Kutner; Margaret Aldrich; Sarju Patel; Joann J Kang; Bijal Amin; Ranon Mann; Ibne Karim M Ali; Roosecelis Brasil Martines; Jennifer Rittenhouse Cope; Graciela O De Boccardo; Yoram A Puius
Journal:  Transpl Infect Dis       Date:  2018-02-12       Impact factor: 2.228

3.  Acute granulomatous acanthamoeba encephalitis in an immunocompetent patient.

Authors:  Peter Lackner; Ronny Beer; Gregor Broessner; Raimund Helbok; Bettina Pfausler; Christian Brenneis; Herbert Auer; Julia Walochnik; Erich Schmutzhard
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

4.  In vitro activity of Acanthamoeba castellanii on human platelets and erythrocytes.

Authors:  A Mattana; L Alberti; G Delogu; P L Fiori; P Cappuccinelli
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

Review 5.  Epidemiology of free-living amoebae in the Philippines: a review and update.

Authors:  Giovanni D Milanez; Frederick R Masangkay; Gregorio L Martin I; Ma Frieda Z Hapan; Edilberto P Manahan; Jeffrey Castillo; Panagiotis Karanis
Journal:  Pathog Glob Health       Date:  2022-02-03       Impact factor: 3.735

6.  Artemisia annua L. as a plant with potential use in the treatment of acanthamoebiasis.

Authors:  Monika Derda; Edward Hadaś; Marcin Cholewiński; Łukasz Skrzypczak; Anna Grzondziel; Agnieszka Wojtkowiak-Giera
Journal:  Parasitol Res       Date:  2016-01-19       Impact factor: 2.289

7.  Clinical Improvement of Disseminated Acanthamoeba Infection in a Patient with Advanced HIV Using a Non-Miltefosine-Based Treatment Regimen in a Low-Resource Setting.

Authors:  Denasha L Reddy; Eunice van den Berg; Wayne Grayson; Matilda Mphahlele; John Frean
Journal:  Trop Med Infect Dis       Date:  2022-02-04

Review 8.  Prevalence of free-living amoebae in swimming pools and recreational waters, a systematic review and meta-analysis.

Authors:  Beni Jequicene Mussengue Chaúque; Denise Leal Dos Santos; Davood Anvari; Marilise Brittes Rott
Journal:  Parasitol Res       Date:  2022-08-30       Impact factor: 2.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.